American Journal of Obstetrics & Gynecology
Volume 198, Issue 1 , Pages 54.e1-54.e4 , January 2008

Pediatric outcome in Rhesus hemolytic disease treated with and without intrauterine transfusion

  • Inge P. De Boer, MD

      Affiliations

    • Division of Neonatology, Department of Pediatrics, Leiden University Medical Center, Leiden, the Netherlands
    • ,
  • Eliane C.M. Zeestraten, MD

      Affiliations

    • Division of Neonatology, Department of Pediatrics, Leiden University Medical Center, Leiden, the Netherlands
    • ,
  • Enrico Lopriore, MD, PhD

      Affiliations

    • Division of Neonatology, Department of Pediatrics, Leiden University Medical Center, Leiden, the Netherlands
    • Corresponding Author InformationReprints: Enrico Lopriore, MD, PhD, Division of Neonatology, Department of Pediatrics, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands
    • ,
  • Inge L. van Kamp, MD, PhD

      Affiliations

    • Division of Fetal Medicine, Department of Obstetrics, Leiden University Medical Center, Leiden, the Netherlands.
    • ,
  • Humphrey H.H. Kanhai, MD, PhD

      Affiliations

    • Division of Fetal Medicine, Department of Obstetrics, Leiden University Medical Center, Leiden, the Netherlands.
    • ,
  • Frans J. Walther, MD, PhD

      Affiliations

    • Division of Neonatology, Department of Pediatrics, Leiden University Medical Center, Leiden, the Netherlands

Received 14 December 2006 ,Revised 8 May 2007 ,Accepted 22 May 2007.

References 

  1. van Kamp IL, Klumper FJ, Meerman RH, Oepkes D, Scherjon SA, Kanhai HH. Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988-1999. Acta Obstet Gynecol Scand. 2004;83:731–737
  2. van Kamp IL, Klumper FJ, Bakkum RS, et al. The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment. Am J Obstet Gynecol. 2001;185:668–673
  3. Bowman JM. The prevention of Rh immunization. Transfus Med Rev. 1988;2:129–150
  4. Jackson JC. Adverse events associated with exchange transfusion in healthy and ill newborns. Pediatrics. 1997;99:E7
  5. Ip S, Chung M, Kulig J, et al. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics. 2004;114:e130–e153
  6. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297–316
  7. Patra K, Storfer-Isser A, Siner B, Moore J, Hack M. Adverse events associated with neonatal exchange transfusion in the 1990s. J Pediatr. 2004;144:626–631
  8. Weiner CP, Williamson RA, Wenstrom KD, et al. Management of fetal hemolytic disease by cordocentesis. II. Outcome of treatment. Am J Obstet Gynecol. 1991;165:1302–1307
  9. Farrant B, Battin M, Roberts A. Outcome of infants receiving in-utero transfusions for haemolytic disease. N Z Med J. 2001;114:400–403
  10. al Alaiyan S, al Omran A. Late hyporegenerative anemia in neonates with rhesus hemolytic disease. J Perinat Med. 1999;27:112–115
  11. Millard DD, Gidding SS, Socol ML, et al. Effects of intravascular, intrauterine transfusion on prenatal and postnatal hemolysis and erythropoiesis in severe fetal isoimmunization. J Pediatr. 1990;117:447–454
  12. Oepkes D, van Kamp IL, Simon MJ, Mesman J, Overbeeke MA, Kanhai HH. Clinical value of an antibody-dependent cell-mediated cytotoxicity assay in the management of Rh D alloimmunization. Am J Obstet Gynecol. 2001;184:1015–1020
  13. Osborn LM, Lenarsky C, Oakes RC, Reiff MI. Phototherapy in full-term infants with hemolytic disease secondary to ABO incompatibility. Pediatrics. 1984;74:371–374
  14. Egberts J, van Kamp IL, Kanhai HH, Meerman RH, Giordano PC, Gravenhorst JB. The disappearance of fetal and donor red blood cells in alloimmunised pregnancies: a reappraisal. BJOG. 1997;104:818–824
  15. Goodrum LA, Saade GR, Belfort MA, Carpenter RJ, Moise KJ. The effect of intrauterine transfusion on fetal bilirubin in red cell alloimmunization. Obstet Gynecol. 1997;89:57–60
  16. Alcock GS, Liley H. Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates. Cochrane Database Syst Rev. 2002;CD003313
  17. Trevett TN, Dorman K, Lamvu G, Moise KJ. Antenatal maternal administration of phenobarbital for the prevention of exchange transfusion in neonates with hemolytic disease of the fetus and newborn. Am J Obstet Gynecol. 2005;192:478–482
  18. Thorp JA, O’Connor T, Callenbach J, et al. Hyporegenerative anemia associated with intrauterine transfusion in rhesus hemolytic disease. Am J Obstet Gynecol. 1991;165:79–81
  19. Ebbesen F. Late anaemia in infants with rhesus haemolytic disease treated with intensive phototherapy. Eur J Pediatr. 1979;130:285–290

 Cite this article as: De Boer IP, Zeestraten ECM, Lopriore E, et al. Pediatric outcome in Rhesus hemolytic disease treated with and without intrauterine transfusion. Am J Obstet Gynecol 2008;198:54.e1-54.e4.

PII: S0002-9378(07)00670-9

doi: 10.1016/j.ajog.2007.05.030

American Journal of Obstetrics & Gynecology
Volume 198, Issue 1 , Pages 54.e1-54.e4 , January 2008

Article Tools